Obesity pharmacotherapy reimagined: The era of multi-receptor agonists and next-generation metabolic modulators, perspectives and controversies. [PDF]
Lempesis IG, Dalamaga M.
europepmc +1 more source
Recent developments in GPCR signalling in appetite regulation. [PDF]
Brittain HR, Gorvin CM.
europepmc +1 more source
Hypothalamus-liver talks: whispers in the language of metabolism. [PDF]
Ferreira V +5 more
europepmc +1 more source
Pancreatic amylin dynamically reconfigures distributed brain networks governing appetite regulation in mice. [PDF]
Gezginer I +5 more
europepmc +1 more source
Diabetes, Protein Misfolding, and Heat Stress: Molecular Insights and Translational Perspectives. [PDF]
Abreu MM, Spitz VH, Smadja DM.
europepmc +1 more source
Conformational Dynamics of Amylin Receptors Revealed by Hydrogen-Deuterium Exchange Mass Spectrometry. [PDF]
Fairweather CJ +6 more
europepmc +1 more source
Inhibition of Human Amylin Aggregation: <i>In Silico</i> and <i>In Vitro</i> Studies. [PDF]
Mizgalska K +5 more
europepmc +1 more source
Eloralintide, a selective, long-acting amylin receptor agonist for treatment of obesity: Phase 1 proof of concept. [PDF]
Bhattachar S +8 more
europepmc +1 more source
Gut Peptide Alterations in Type 2 Diabetes and Obesity: A Narrative Review. [PDF]
Tzeravini E +4 more
europepmc +1 more source

